Author(s):
National experts point to key developments in rheumatology to watch in the coming year.
Rilzabrutinib Yields Responses in Angioedema in People With CS Urticaria
Diabetes Dialogue: Omnipod 5 and Medtronic 780G for Type 2 Diabetes
New 5-Year Data Show Stability of Deucravacitinib Safety for Those with Psoriasis
Kidney Compass: Applying Hierarchical Composite Endpoints in Kidney Disease Trials
Female Dialysis Patients Face Greater Infection, Withdrawal-Related Mortality Risk
FDA Clears GlutenID Test for Easier Celiac Screening